Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
about
B cells as biomarkers: predicting immune checkpoint therapy adverse events.New and emerging therapies for acute and chronic graft versus host disease.B-cell targeting in chronic Graft-versus-Host disease.Biomarkers for post-transplantation outcomes.Inhibiting Bruton's Tyrosine Kinase Rescues Mice from Lethal Influenza Induced Acute Lung Injury.Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Malignancies.B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ InhibitorsPatient-reported outcomes and health status associated with chronic graft--host diseaseHow ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
P2860
Q47225274-5D6D8B04-E90F-4A4A-89AE-D5C2A6EFCD92Q49238507-C3757914-956A-4D08-B378-9760EF86C817Q50044417-54EC1982-80BB-46A9-9B91-57E52040A2D1Q52603913-3730EE0A-8875-4926-BE78-033CAFF4D3E9Q52667392-840614BE-32F1-4A89-B9EB-0A3560D92642Q52687293-38E50973-BB79-441A-8392-6FAD28BB5C46Q54122926-0F102203-5B2B-4BCD-8B05-7EDD83F73837Q54980047-224E95FA-8C3A-4103-A424-CE8BC5870A27Q55375763-DBC7D5B5-577A-4D35-8F74-08E0DB7CC0CEQ55515367-9799D479-5229-442D-912E-BC4ACE17E38BQ57167736-F145DB95-5761-4DCD-A58E-DDD20E7FE1C1Q58777001-442E6832-BA69-43AD-AB32-7C92F4A232BDQ58782275-E95EE525-C8BC-4229-8D3B-9368D1647D8B
P2860
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
@en
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
@nl
type
label
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
@en
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
@nl
prefLabel
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
@en
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
@nl
P2093
P2860
P1433
P1476
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
@en
P2093
Aaron C Logan
Corey S Cutler
Danelle F James
David Miklos
Edmund K Waller
Iskra Pusic
Jason Dubovsky
Lori Styles
Madan Jagasia
P2860
P304
P356
10.1182/BLOOD-2017-07-793786
P407
P577
2017-09-18T00:00:00Z